🇺🇸

US SEC Filing Intelligence

· daily

Global High-Priority Regulatory Events — April 16, 2026

Across 50 filings in the 'Global High Priority Market Events' stream, proxy statements dominate (e.g., Arbor Realty, Excelerate Energy, Immunocore, Smith Micro, multiple bancorps) signaling peak 2026 AGM season with director elections, equity plans, and say-on-pay votes clustered in May-June. Financial trends show robust revenue growth in large caps like TSMC (+31.6% YoY to NT$3.8T, margins to 59.9%), PepsiCo (+8.6% YoY Q1 to $19.4B, OP +24.4%), Bilibili (+13.1% YoY to RMB30.3B with profit swing), but microcaps exhibit persistent losses narrowing (e.g., SEATech -75% YoY, Catalyst Crew -95% op ex) amid zero revenue and going concern doubts (Horizon Quantum, Ionetix, Data443). M&A/divestitures active: ESCO acquiring Megger ($1.5B financing), CareDx divesting Lab Products ($170M cash), Qwest debt exchange to simplify structure post-$5.75B asset sale. Indian filings highlight distress (AYM Syntex amalgamations, Future Consumer insolvency hearing, open offers at premiums). Capital allocation leans to deleveraging (Lumen/Qwest repaid $4.8B debt) and liquidity boosts (Lincoln Ed $125M facility). Portfolio-level: 12/25 with PoP data show avg revenue +15% YoY but mixed profitability; sector outliers in semis/consumer bullish, small caps bearish. Implications: Near-term catalysts from May meetings could drive volatility; favor large-cap growth over microcap risks.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — April 16, 2026

Across 32 filings primarily covering FY2025 10-Ks and Q1 2026 10-Qs, sentiment is overwhelmingly mixed (25/32), with microcap/development-stage firms (e.g., SEATech, JOCOM, Catalyst Crew) showing narrowed losses via expense cuts (avg ~70% improvement in 8 cases) but persistent zero revenue and going concern risks, while larger caps like PepsiCo (+8.6% revenue YoY), Fastenal (+12.4%), and Travelers (+333% net income) drove positive trends. Portfolio-level, revenue grew in 12/32 (avg +20% YoY where positive), but declined in 14 (avg -40%), with gross margins compressing in 10/32 (avg -200bps, e.g., Lakeland -820bps). Acquisitions/share issuances boosted assets in 15 firms (avg +100% YoY), but cash burn persists in 20+, offset by financing. Capital allocation leans toward buybacks/dividends in stables (Travelers $1.8B buyback, Fastenal dividend +12%), signaling conviction, while microcaps dilute via issuances. Key implication: Opportunities in turnaround microcaps narrowing losses and established consumer/insurance names, but watch margin pressures and working capital deficits amid 2026 economic uncertainty.

32 high priority 32 total filings
· daily

US SEC Trading Suspension Halt Orders — April 16, 2026

The single filing in the USA Trading Suspensions stream highlights a critical Nasdaq compliance deficiency for Fathom Holdings Inc. (FTHM), with its bid price below $1.00 for 30 consecutive business days as of April 10, 2026, violating Listing Rule 5550(a)(2). No period-over-period financial trends, insider activity, capital allocation, or forward-looking guidance beyond compliance are detailed in the enriched data, limiting quantitative comparisons across companies. The negative sentiment (9/10 materiality) signals heightened delisting risk, with 180 days until October 7, 2026, to regain a $1.00+ bid for 10 consecutive days under Rule 5810(c)(3)(A). Failure could trigger delisting, though a second 180-day period is possible if other Capital Market standards are met. This isolated event underscores small-cap vulnerability to regulatory halts amid potential sector weakness, with no immediate listing impact but evaluating options like reverse stock split. Portfolio implications point to monitoring similar bid-price deficient names for cascading suspension risks.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — April 16, 2026

Across 37 filings in the USA Corporate Distress & Bankruptcy stream, acute distress signals are limited to covenant breaches (Katapult's 10th waiver) and Nasdaq delisting risks (Fathom), but the dominant theme is aggressive liquidity accumulation via $5B+ in combined equity/debt raises, facility expansions, and refinancings, suggesting pre-emptive balance sheet fortifications amid potential sector headwinds. Standout period growth includes CareDx's Q1 revenue +39% YoY to $118M (Testing Services +48% YoY), Lincoln Educational's student starts +19-20% Q1 2026, contrasting Katapult's origination/charge-off defaults. Biotech leads capital inflows (Spyre $463M, Achieve $354M, TeraWulf $1.036B), while ABS issuances (GM $1.27B, Toyota $1.9B, BMW $1.5B) remain stable. No insider trading or dividend/buyback activity reported; forward-looking catalysts cluster in late April-May closings and Q3 divestitures. Portfolio-level implications: Microcap distress outliers amid broader turnaround maneuvers, with dilution risks from equity raises but enhanced liquidity for 20+ companies signaling resilience over collapse.

37 high priority 37 total filings
· daily

US Executive Officer Management Changes SEC — April 16, 2026

Across 39 filings on USA Executive & Director Changes from April 16, 2026, the dominant theme is a high volume of C-suite and board transitions, with 18 new CEO/CFO appointments or promotions (e.g., Eton Pharma, First Business, AMERISAFE, TON Strategy, Lifevantage, Prime Medicine) and 22 resignations/retirements (e.g., Sensei Bio conditional board overhaul, Rivulet CEO, Zscaler EVP), signaling planned successions amid growth phases but no widespread distress. Positive sentiment prevails in 11 cases (28%), particularly pharma/biotech hires with pedigrees from AstraZeneca/Novartis (Aktis), Nature’s Sunshine revenue +45% (Lifevantage), driven by experienced leaders; neutral in 25 (64%), mixed in 3. No explicit YoY/QoQ revenue declines noted, but forward-looking comp packages show aggressive incentives: avg new CEO base ~$650k, bonuses 40-60%, equity 1-2% shares, RSUs up to $215k vesting 5yrs. Capital allocation tilts to equity incentives over dividends/buybacks, with 8 firms issuing PSUs/RSUs/MIPs tied to EPS CAGR/TSR through 2030. Sector patterns emerge in financials (smooth annual meetings, equity plans approved) and pharma (high materiality 7-9/10 transitions). Implications: opportunities in growth-oriented small caps post-transition, risks from conditional changes (Sensei) and restructurings (MiMedx $40M savings but $4M charge).

39 high priority 39 total filings
· daily

US Corporate Board Director Changes SEC Filings — April 16, 2026

Across 39 filings on USA Board Room Changes from April 16, 2026, a dominant theme is C-suite transitions, with 12 CFO appointments/promotions (e.g., Eton, Amerisafe, Prime Medicine) and 7 CEO changes (e.g., First Business, LifeVantage), signaling proactive succession planning amid growth phases in biotech/pharma (8/39 positive sentiment) and financials. Board refreshments are prevalent, with 15 new director appointments (e.g., Myomo, Aktis Oncology) featuring executives with proven revenue growth track records (e.g., LifeVantage CEO +45% revenue), while 14 resignations/step-downs (e.g., Zscaler EVP, Greenidge directors) cite personal reasons/no disagreements, suggesting orderly handovers. No broad YoY revenue declines noted, but mixed signals in financials like WesBanco's narrow 45.7M vs 25M say-on-pay vote (high opposition) contrast positive equity plan approvals (e.g., Farmers National 1M shares reserved). Sentiment skews positive/neutral (34/39), with biotech hires boosting operational metrics like pipeline advancement (Aktis, Xilio); capital allocation favors equity incentives (e.g., Quanta PSUs up to 600% payout by 2030). Implications: Bullish for small-cap biotechs with experienced leadership upgrades, watch financials for comp scrutiny; portfolio trend of internal promotions (4/12 CFOs) indicates stability vs external hires signaling transformation.

39 high priority 39 total filings
· daily

US Merger & Acquisition SEC Filings — April 16, 2026

Across four US SEC filings in the M&A & Takeover stream, themes center on SPAC lifecycle extensions and separations (2/4 filings), a biotech asset acquisition with mixed Phase 3 data, and a radioisotope producer's financing amid deepening losses. Period-over-period trends show stark contrasts: Ionetix revenue surged 67.7% YoY to $6.0M for FY2025 but net loss widened 32.0% YoY to $39.7M, cash plummeted 94.6% to $0.3M, and assets fell 11.6% to $35.0M; MeiraGTx's acquisition highlights strong secondary endpoints (e.g., p=0.006 LLQ PRO mobility) despite primary endpoint miss. SPACs Compass and SUMA extended timelines to July 2026 and enabled unit separations from April 20, 2026, signaling prolonged target hunts in tech-enabled sectors. Mixed/neutral sentiments dominate (3/4), with high materiality in Ionetix (going concern doubts) and MeiraGTx ($25M J&J deal for 2027 launch). Portfolio-level patterns indicate resilient M&A pursuit amid liquidity pressures, with biotech outliers in asset deals and SPACs comprising 50% of activity, implying near-term catalysts in business combinations.

4 high priority 4 total filings
· monthly

US Pre-Market SEC Filings Roundup — April 16, 2026

Across 50 overnight SEC filings from April 15-16, 2026, overarching themes include robust revenue growth in select large-cap tech/semiconductor names like TSMC (+31.6% YoY to NT$3.8T) and Bilibili (+13.1% YoY with profit turnaround), contrasted by persistent losses and margin pressures in small-cap industrials and tech (e.g., Capstone op loss widened to $11M, Ionetix net loss +32% to $39.7M). Portfolio-level trends show 12/20 10-K/A filings with revenue growth averaging +40% YoY (outliers: NextNRG +195%, China Foods +40.5%), but net losses narrowing in only 7/15 cases amid cost cuts; gross margins improved in 6/12 (avg +150bps, led by TSMC + to 59.9%). Critical developments feature CareDx's $170M Lab divestiture (close Q3 2026), PepsiCo's affirmed FY26 guidance (organic rev 2-4%, EPS +4-6%) and +4% dividend, and multiple proxy votes for buybacks/equity plans. Sector patterns highlight financials' routine proxies (positive undertones in First Financial M&A), energy/utilities mixed (NextNRG rev surge vs Energy Co net income -4%), and small-cap going concern risks (5 flags). Market implications: Favor large-cap outperformers for growth; caution on microcaps with liquidity crunches; watch May-June AGMs for capital allocation votes.

27 high priority 23 medium 50 total filings
· daily

DHS Homeland Security Contracts — April 15, 2026

DHS represents the sole agency in this $329,952,976 obligation period, fully civilian with 0/1 defense-related contracts and a neutral average signal strength of 4.0/10. General Dynamics Information Technology, Inc. (General Dynamics Corp subsidiary) secured the highest-materiality award, a $329,952,976 cost-plus-fixed-fee delivery order from U.S. Citizenship and Immigration Services (USCIS) for IT sustainment services under full and open competition. The contract's performance ended in 2015-09-25 with $0 outlayed to date despite 20 subawards worth $156,598,839, indicating dormant historical backlog in DHS IT facilities management (NAICS 541513). Highest-conviction signal is neutral due to expired term and lack of spending activity. Key watch item is total outlayed amount and any post-2015 modifications or extensions.

1 total filings
· daily

New Federal Contractors — April 15, 2026

$3,349,025,927 in total obligations across 9 new federal contracts from April 15-15, 2026, are entirely civilian (0/9 defense-related), dominated by long-term IT, consulting, and support services awards to small businesses and subsidiaries from agencies including State ($2.31B), DOE ($294M combined), DHS ($330M), HHS ($88M), and Treasury ($128M). Highest-conviction bullish signal is XATOR LLC's $2.31B Department of State award, providing massive revenue visibility despite limited details. Neutral signals from historical contracts like General Dynamics IT's $330M DHS deal (with $0 outlayed post-2015) temper enthusiasm. Key risk is uneven outlay progress, with several contracts showing partial spending (e.g., 47-82% outlayed) and reliance on unexercised options.

9 total filings
· daily

Significant Contract Modifications ($10M+) — April 15, 2026

These 10 significant contract modifications total $3,349,099,541 in obligations, with 0/10 defense-related—all civilian agencies including State, DHS, DOE, HHS, Treasury, NASA, USAID, PBGC, and Commerce. Dominant themes are long-duration IT, professional services, and specialized equipment contracts, heavily weighted toward small businesses via set-asides or open competition. Highest-conviction bullish signal is XATOR LLC's $2,309,491,422 Department of State award (materiality 8/10), providing massive revenue potential despite sparse details. UNWIN CO's $213,772,540 DOE set-aside and SOFTRAMS LLC's $88,157,680 HHS delivery order further highlight small-business growth in security and healthcare IT. Key risk: stalled outlays on historical contracts like General Dynamics Information Technology's $329,952,976 DHS award (ended 2015, $0 outlayed). Watch option exercises and remaining obligations across long-term deals through 2032.

10 total filings
· daily

Contract Deobligations Alert — April 15, 2026

This Contract Deobligations Alert synthesizes $3,349,099,541 in total obligations across 10 civilian agency contracts from April 15, 2026, with 0/10 defense-related and average signal strength of 5.3/10. Dominant themes include long-duration IT, professional services, and specialized equipment awards to agencies like Department of State (69% of total via XATOR LLC's $2.31B), DOE ($214M UNWIN + $80M Bluewater), and HHS ($88M SOFTRAMS). Highest-conviction bullish signal is XATOR LLC's $2.31B Department of State award, providing massive revenue visibility despite unknown revenue/pricing details. Balanced signals show 7 bullish amid 3 neutrals, with no bearish. Key risk/watch item: stalled outlays on historical contracts like General Dynamics IT's $330M DHS award (ended 2015, $0 outlayed) and Lockheed Martin's $73,614 Commerce purchase ($0 outlayed), signaling potential deobligation exposure.

10 total filings
· daily

Contract Option Exercises — April 15, 2026

This digest covers $3,349,099,541 in contract option exercises across 10 awards from April 15-15, 2026, all from civilian agencies with zero defense-related activity. The portfolio is dominated by Department of State's $2.31B award to XATOR LLC, representing 69% of total value and the highest-conviction bullish signal for long-term revenue in security services. Other notable themes include DOE's sustained IT and security support to UNWIN CO ($213.8M) and Bluewater Federal Solutions ($80M, Tetra Tech subsidiary), alongside HHS/CMS IT to SOFTRAMS LLC ($88.2M). Key risk is uneven outlay execution, with GDIT's $330M DHS contract at $0 outlayed post-2015 performance end and several relying on unexercised options. Investors should monitor outlay progress and option exercises for revenue realization in civilian IT/services exposure.

10 total filings
· daily

Federal Professional Services Contracts — April 15, 2026

Two DOE professional services contracts totaling $293,785,850 in obligations highlight sustained civilian agency spending on security studies and IT support, with 0/2 defense-related awards. UNWIN CO's $213.8M small business set-aside contract (materiality 8/10) leads as the highest-conviction bullish signal, featuring $178.6M already outlayed and revenue visibility through April 2026. Bluewater Federal Solutions, Inc. (Tetra Tech, Inc. subsidiary) adds $80M obligated (potential $96.9M ceiling) in IT services, with $62.8M outlayed through September 2026. Dominant theme is DOE Headquarters Procurement Services prioritizing long-duration time-and-materials awards to small businesses. Key watch item: outlay progress on remaining balances amid 2026 contract end dates.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — April 15, 2026

These three civilian federal IT and cybersecurity contracts total $482,277,261 in obligations, with 0/3 defense-related, highlighting momentum in civilian agency spending on IT services via full and open competition. Dominant themes include historical DHS backlog for General Dynamics Information Technology, Inc. and long-term growth commitments to small businesses SOFTRAMS LLC at HHS/CMS ($88M obligated, $57M outlayed) and CLOUDSHAPE LLC at USAID ($64M obligated, $33M outlayed). Highest-conviction signals are bullish on SOFTRAMS LLC and CLOUDSHAPE LLC due to significant outlays and multi-year horizons extending to 2029 and 2032. A key risk is zero outlays on the largest contract to General Dynamics Information Technology, Inc. ($330M DHS obligation, performance ended 2015), signaling dormant backlog.

3 total filings
· daily

All HHS Contracts — April 15, 2026

HHS awarded a single $88,157,680 obligation delivery order to SOFTRAMS LLC under full and open competition, representing 100% civilian contracts with zero defense exposure during the April 15, 2026 period. The contract supports CMS's Quality Payment Program via custom computer programming services (NAICS 541511), with $56,978,236 already outlayed and potential expansion to $195,527,844 including options. This signals a major revenue commitment for the small HUBZone, minority-owned firm, providing ~$15-17M in estimated annual revenue over ~5.75 years. Highest-conviction bullish signal is immediate revenue recognition from high outlays on this firm fixed price award. Key watch item: option exercises toward the $195M ceiling and outlay progression versus total obligation. High pricing risk exists due to the firm fixed price structure.

1 total filings
· daily

All DOE Contracts — April 15, 2026

DOE awarded $293,785,850 in total obligations across two long-term civilian contracts during the April 15, 2026 period, with 0/2 defense-related and both signaling bullish revenue visibility through 2026. Dominant themes center on DOE Headquarters Procurement Services funding security studies/analysis (UNWIN CO at $213.8M) and IT/engineering support (Bluewater Federal Solutions at $80M), both time-and-materials structures with substantial outlays ($178.6M and $62.8M respectively). Highest-conviction signal is UNWIN CO's small business set-aside securing dedicated ~$35M annual revenue through April 2026 amid strong execution. A key risk is medium pricing risk on time-and-materials terms, with investors watching remaining outlay progress and option exercises toward full ceilings.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — April 15, 2026

These four civilian mega contracts totaling $2,981,670,287 across Department of State, DHS, DOE, and Treasury highlight sustained funding in security consulting, IT services, and specialized manufacturing, with zero defense exposure. XATOR LLC's $2.31B Department of State award leads as the highest-conviction bullish signal due to its top materiality score of 8/10. UNWIN CO's $213.8M DOE small business set-aside through 2026-04-13 adds revenue visibility with $178.6M already outlayed. Key risk is General Dynamics Information Technology's $330M DHS contract showing $0 outlayed since its 2015 end date, signaling dormant historical backlog.

4 total filings
· daily

High-Value Federal Grants ($5M+) — April 15, 2026

This digest covers $3,349,025,927 in high-value federal grants ($5M+) awarded or active during April 15, 2026, with 0/9 defense-related and all civilian agency obligations. Dominant themes include long-duration IT and technical support contracts to DOE ($293.8M across UNWIN CO and Bluewater Federal Solutions), HHS ($88.2M to SOFTRAMS LLC), and DHS ($330M to General Dynamics IT), signaling steady civilian spending in IT services and security analysis. Highest-conviction bullish signal is XATOR LLC's $2.31B Department of State contract (materiality 8/10), providing massive revenue potential despite limited details. Key risk is execution uncertainty from low or zero outlays on historical contracts like General Dynamics IT's $330M DHS award ($0 outlayed post-2015). Investors should monitor option exercises and outlay progress for revenue realization in public parents like General Dynamics (GD) and Tetra Tech (TTEK).

9 total filings
· daily

DOE Energy Grants — April 15, 2026

Two DOE contracts totaling $293,785,850 in obligations highlight sustained civilian agency spending on long-duration technical support services, with 0/2 defense-related and both running through mid-to-late 2026. UNWIN CO's $213,772,540 small business set-aside for security studies/analysis (materiality 8/10) represents the highest-conviction bullish signal, providing ~$35M annual revenue visibility amid $178.6M already outlayed. Bluewater Federal Solutions, Inc. (Tetra Tech, Inc. subsidiary) adds $80,013,310 for IT support with $62.8M outlayed and potential to $96.9M ceiling. Dominant theme is DOE Headquarters Procurement Services prioritizing time-and-materials vehicles for enterprise support. Key watch item: outlay progress on remaining balances ($35M for UNWIN, ~$17M+ for Bluewater) ahead of 2026 performance end dates.

2 total filings